Advertisement

Cruising for a Bruising

  • Mark T. Friedman
  • Kamille A. West
  • Peyman Bizargity
  • Kyle Annen
  • Jeffrey S. Jhang
Chapter

Abstract

A 41-year-old woman with a history of menorrhagia is referred to the emergency department (ED) because of severe anemia, hemoglobin (Hgb) level 5.5 g/dL, and dyspnea on exertion. The patient has had multiple pregnancies but no transfusions and reports taking no medications other than over-the-counter multivitamins. A type and screen sample (ethylenediaminetetraacetic acid [EDTA] anticoagulant) is submitted to the blood bank along with a request for transfusion of two units of red blood cells (RBCs).

Keywords

Fetal and neonatal alloimmune thrombocytopenia/FNAIT Hemovigilance HPA-1a Post-transfusion purpura/PTP Thrombocytopenia 

References

  1. 1.
    Mazzei CA, Popovsky MA, Kopko PM. Noninfectious complications of blood transfusion. In: Fung MK, Grossman BJ, Hillyer CD, Westhoff CM, editors. Technical manual. 18th ed. Bethesda: AABB; 2014. p. 688–90.Google Scholar
  2. 2.
    Peterson JA, McFarland JG, Curtis BR, Aster RH. Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management. Br J Haematol. 2013;161(1):3–14.CrossRefGoogle Scholar
  3. 3.
    Schwartz J, Padmanbhan A, Aqui N, Balogun RA, Connelly-Smith L, Delaney M, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American Society of Apheresis: the seventh special issue. J Clin Apheresis. 2016;31:285–6.Google Scholar
  4. 4.
    Centers for Disease Control and Prevention. National healthcare safety network biovigilance component, hemovigilance module surveillance protocol v. 2.1.3, Atlanta, GA. August 2014. www.CDC.gov/nhsn. Accessed 5 May 2015.
  5. 5.
    Chung K-W, Harvey A, Basavaraju SV, Kuehnert MJ. How is national recipient hemovigilance conducted in the United States? Transfusion. 2015;55:703–7.CrossRefGoogle Scholar
  6. 6.
    Serrarans-Janssen JM, Semmekrot BA, Novotny VM, Porcelijin L, Lotgering FK, Delemarre FM, Steegers EA. Fetal/neonatal allo-immune thrombocytopenia (FNAIT): past, present, and future. Obstet Gynecol Surv. 2008;63(4):239–52.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Mark T. Friedman
    • 1
  • Kamille A. West
    • 2
  • Peyman Bizargity
    • 3
  • Kyle Annen
    • 4
  • Jeffrey S. Jhang
    • 1
  1. 1.Icahn School of MedicineMount Sinai Health SystemNew YorkUSA
  2. 2.Department of Transfusion MedicineNational Institutes of Health Clinical CenterBethesdaUSA
  3. 3.Department of Molecular & Human GeneticsBaylor College of MedicineHoustonUSA
  4. 4.Department of PathologyChildren’s Hospital ColoradoAuroraUSA

Personalised recommendations